Appointment of liquidators (MVL)
MERCURY MEDICAL REPORTING LIMITED
MERCURY MEDICAL REPORTING LIMITED has appointed Simon David Chandler and Lucy Law as liquidators in a members' liquidation on 4 August 2026.
Notice details
- Company
- MERCURY MEDICAL REPORTING LIMITED
- Company number
- 07037031
- Nature of business
- Other human health activities
- Registered office
- c/o Forvis Mazars LLP, 30 Old Bailey, London, EC4M 7AU
- Type of liquidation
- Members
- Date of appointment
- 4 August 2026
- Liquidator(s)
- Simon David Chandler (IP No. 008822); Lucy Law (IP No. 30946)
- Appointed by
- Members
How does this notice affect you?
Choose what applies and we'll point you at the right next step.
A written-off invoice rarely stops at the company that failed. The supplier left short is often the next business in difficulty — and the earlier that's dealt with, the more options stay open. If MERCURY MEDICAL REPORTING LIMITED owed you money, it's worth checking where that leaves you.
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from K2. The insolvency practitioner named in this notice should send you a case reference — you'll need it to claim.
K2 has backed and restructured UK businesses since 1990, including buying trade and assets out of distress. These situations move in days rather than months, so if you're looking at MERCURY MEDICAL REPORTING LIMITED or something similar, start the conversation early.
A members' voluntary liquidation is a solvent, orderly closure — often part of retirement, a group restructure, or moving on to the next venture. K2 has advised UK company directors since 1990 on restructuring and what comes next. If that's on your horizon, talk to us.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.